Medical Industry Feature highlights topics brought to you by makers of products and services in the medical industry.
Navigating Treatment Goals With a CDK4/6 Inhibitor in HR+/HER2- mBC
Partial Response in Major Depressive Disorder Treatment: Are We Doing Enough?
Understanding PTSD: The Impact of a Prevalent Mental Health Disorder
John Krystal, MD
PeerAddressing Unresolved Symptoms of Major Depressive Disorder
Conversations With Cardiologists: Clinical Perspectives on the Treatment of HFmrEF and HFpEF
Primary Hyperlipidemia: Fresh look at an LDL-C Therapy and its Long-Term Data
Engaging Neuroplasticity in Depression with Cognitive-Emotional Training
A Look at the Long-Term Data on a Therapy for Virologically Suppressed Adults
The Importance of Pursuing Novel Treatments for Major Depressive Disorder
Aderonke Pederson, MD
PeerUpdates in CLL Treatment: 5-Year Off Treatment Analyses of the CLL14 and MURANO Trials
Exploring the Use of Peptide-Based Formulas in Enteral Nutrition Therapy
Overcoming Real World Challenges of LDL-C Management: Looking Beyond Statin Therapy
The Four-Hit Model of IgA Nephropathy Pathogenesis
Jai Radhakrishnan, MD
PeerReshaping LDL-C Management in Primary Hyperlipidemia with First-in-Class siRNA Therapy